Vistagen Therapeutics (VTGN) Change in Receivables (2010 - 2021)
Vistagen Therapeutics (VTGN) posted Change in Receivables of -$40600.0 for Q3 2021, down 138.23% sequentially from $106200.0 in Q2 2012.
Vistagen Therapeutics (VTGN) Change in Receivables (2010 - 2021) Analysis & Trends
Vistagen Therapeutics has reported Change in Receivables for 4 years, with the latest figure at -$40600.0 in Q3 2021.
- Quarterly Change in Receivables changed N/A year-over-year to -$40600.0 in Q3 2021, while the trailing twelve-month figure through Sep 2021 was -$40600.0 (changed N/A YoY) and the FY2013 annual result came in at $106200.0, up 265.94% from the prior year.
- Change in Receivables eased to -$40600.0 in Q3 2021 per VTGN's latest filing, from $106200.0 in the prior quarter.
- Over five years, Change in Receivables peaked at -$40600.0 in Q3 2021 and troughed at -$40600.0 in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -53.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 117.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 31.60 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 94.29 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 37.16 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Vistagen Therapeutics | 10.49 Mn | 10.49 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | -40,600.00 |
| Sep 30, 2021 | -40,600.00 |
| Jun 30, 2012 | 106,200.00 |
| Jun 30, 2012 | 106,200.00 |
| Mar 31, 2012 | -98,400.00 |
| Mar 31, 2012 | -98,400.00 |
| Dec 31, 2011 | 119,200.00 |
| Dec 31, 2011 | 119,200.00 |
| Sep 30, 2011 | 21,500.00 |
| Sep 30, 2011 | 21,500.00 |
| Jun 30, 2011 | -106,300.00 |
| Jun 30, 2011 | -106,300.00 |
| Mar 31, 2011 | 196,773.00 |
| Mar 31, 2011 | 196,773.00 |
| Dec 31, 2010 | -189,646.00 |
| Dec 31, 2010 | -189,646.00 |
| Sep 30, 2010 | 841.00 |
| Sep 30, 2010 | 841.00 |
| Jun 30, 2010 | 197,032.00 |
| Jun 30, 2010 | 197,032.00 |